Disclosure Of Material Accounting Policy Information [Text Block]

PCI Biotech Holding - Filing #5867918

Concept 2024-01-01 to
2024-12-31
Disclosure of material accounting policy information [text block]
Description of accounting policy for deferred income tax [text block]
b) Taxes  
Description of accounting policy for derecognition of financial instruments [text block]
d) Financial
Description of accounting policy for earnings per share [text block]
e) Share-based
Description of accounting policy for expenses [text block]
c) Intangible
Description of accounting policy for functional currency [text block]
NOK (Norwegian kroner) is the functional currency for all companies within the Group. The Group’s  
Description of accounting policy for government grants [text block]
a) Government
Description of accounting policy for impairment of non-financial assets [text block]
The Group has currently no development expenditure that qualifies for recognition as an asset under  
Description of accounting policy for subsidiaries [text block]
Accounting policies only relevant for the Parent separate financial statement:  

Talk to a Data Expert

Have a question? We'll get back to you promptly.